Inventor · disambiguated record
Michael Soth
Also filed as: SOTH MICHAEL · SOTH MICHAEL J
50 granted patents·13 pending applications·449 citations·filing 2004–2025
98Inventor score
Files withUNIV TEXAS29ROCHE PALO ALTO LLC13DEWDNEY NOLAN JAMES5HENDRICKS ROBERT THAN4HOFFMANN LA ROCHE3
Top patents by PatentIndex Score
63 records- 0197US7902197B2Pyrrolopyrazine kinase inhibitorsROCHE PALO ALTO LLC·Filed 2009·Granted Mar 8, 2011·106 cites·23 claims
- 0296US11603365B2Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2020·Granted Mar 14, 2023·4 cites·30 claims
- 0396US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0495US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0595US10899740B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·8 cites·15 claims
- 0695US7939531B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted May 10, 2011·61 cites·32 claims
- 0794US12186324B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2021·Granted Jan 7, 2025·3 cites·26 claims
- 0894US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0994US10150753B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2016·Granted Dec 11, 2018·7 cites·15 claims
- 1094US7902194B2Inhibitors of bruton's tyrosine kinaseRoche Palo Alto·Filed 2009·Granted Mar 8, 2011·33 cites·7 claims
- 1193US11713313B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Aug 1, 2023·3 cites·12 claims
- 1293US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 1393US7906509B2Inhibitors of bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 15, 2011·26 cites·21 claims
- 1492US10738043B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2018·Granted Aug 11, 2020·6 cites·12 claims
- 1592US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 1692US8124604B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2011·Granted Feb 28, 2012·22 cites·23 claims
- 1791US10125128B2GLS1 inhibitors for treating diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Nov 13, 2018·13 cites·21 claims
- 1891US7683064B2Inhibitors of Bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 23, 2010·22 cites·19 claims
- 1990US7943618B2Btk protein kinase inhibitorsROCHE PALO ALTO LLC·Filed 2008·Granted May 17, 2011·18 cites·8 claims
- 2089US11058688B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jul 13, 2021·3 cites·41 claims
- 2189US8324211B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2009·Granted Dec 4, 2012·14 cites·6 claims
- 2287US7435731B2Substituted pyrazolo[3,4-d]pyrimadines and methods of using the sameROCHE PALO ALTO LLC·Filed 2005·Granted Oct 14, 2008·11 cites·16 claims
- 2386US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2485US10899769B2Imidazopiperazinone inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·3 cites·26 claims
- 2585US10093664B2Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of diseaseUNIV TEXAS·Filed 2017·Granted Oct 9, 2018·4 cites·24 claims
- 2684US12252480B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2023·Granted Mar 18, 2025·0 cites·10 claims
- 2783US11560366B2Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Jan 24, 2023·1 cites·24 claims
- 2882US8822457B2Inhibitors of bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2013·Granted Sep 2, 2014·4 cites·6 claims
- 2980US8618098B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2012·Granted Dec 31, 2013·4 cites·6 claims
- 3080US2025127792A1Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 3178US8901124B2Pyridazine amide compounds useful as SYK inhibitorsHOFFMANN LA ROCHE·Filed 2013·Granted Dec 2, 2014·4 cites·13 claims
- 3278US8012974B2Pyrrolopyrazinyl urea kinase inhibitorsROCHE PALO ALTO LLC·Filed 2009·Granted Sep 6, 2011·3 cites·31 claims
- 3377US8008298B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted Aug 30, 2011·3 cites·42 claims
- 3475US10428057B2Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of diseaseUNIV TEXAS·Filed 2018·Granted Oct 1, 2019·1 cites·46 claims
- 3575US8673905B2Imidazo pyrazinesLUK KIN-CHUN·Filed 2012·Granted Mar 18, 2014·5 cites·32 claims
- 3675US8536166B2Inhibitors of Burton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2009·Granted Sep 17, 2013·2 cites·27 claims
- 3775US8426441B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2008·Granted Apr 23, 2013·2 cites·21 claims
- 3875US2025250253A1Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2025·Application pending·0 cites
- 3974US8618103B2Inhibitors of JAKDE VICENTE FIDALGO JAVIER·Filed 2010·Granted Dec 31, 2013·4 cites·27 claims
- 4072US7517901B2p38 MAP kinase inhibitors and methods for using the sameROCHE PALO ALTO LLC·Filed 2006·Granted Apr 14, 2009·1 cites·6 claims
- 4172US2022267311A1Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of diseaseUNIV TEXAS·Filed 2022·Application pending·0 cites
- 4271US8658646B2Pyrrolopyrazine kinase inhibitorsCHEN SHAOQING·Filed 2012·Granted Feb 25, 2014·3 cites·17 claims
- 4365US2025049809A1Inhibitors of mutant idh1 and idh2UNIV TEXAS·Filed 2024·Application pending·0 cites
- 4453US7365211B2Heterocyclic GABAA subtype selective receptor modulatorsROCHE PALO ALTO LLC·Filed 2004·Granted Apr 29, 2008·1 cites·5 claims
- 4552US2014155376A1Pyrrolopyrazine kinase inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4650US2025243209A1Heterocycles as modulators of nsd activityUNIV TEXAS·Filed 2025·Application pending·0 cites
- 4748US11046649B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 4846US8426409B2Inhibitors of Bruton's tyrosine kinaseKONDRU RAMA K·Filed 2009·Granted Apr 23, 2013·0 cites·8 claims
- 4945US7601726B2Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Oct 13, 2009·0 cites·17 claims
- 5045US7566708B2Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Jul 28, 2009·0 cites·3 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Soth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →